Company intelligence / Profile preview

BioConnection

Ownership: Private
Employees: ~80
Development stage: Commercial

Overview

BioConnection provides contract development and manufacturing services for injectable biopharmaceutical products. It offers GMP-compliant aseptic filling, freeze-drying, terminal sterilization, batch certification, and packaging. The company serves small to medium-sized biopharma clients from early clinical through commercial production. Facilities are FDA and EMA approved with a strong track record in both regulatory environments. No proprietary drug pipeline—focuses on enabling client product development and commercialization.

Modalities: ProteinsPeptidesAntibodiesInjectable (bio)pharmaceuticalsMicrospheresSmall molecules
Industry: Contract Manufacturing Organization

Partnerships

Gimv (investment partner)Numerous partnerships with small/medium biopharma companies as clients.

Beyond the preview

Go deeper on BioConnection.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioConnection.

Explore the full profile